GoodRx Holdings, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2019 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
GoodRx Holdings, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2019 to Q2 2024.
  • GoodRx Holdings, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 385M shares, a 7.15% decline year-over-year.
  • GoodRx Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 410M shares, a 0.62% decline from 2022.
  • GoodRx Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 413M shares, a 0.7% increase from 2021.
  • GoodRx Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 410M shares, a 49.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 385M -29.6M -7.15% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 390M -22.4M -5.43% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 410M -2.54M -0.62% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 413M +481K +0.12% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 414M +2.2M +0.53% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 412M -14.9M -3.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 413M +2.88M +0.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 413M +1.73M +0.42% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 412M -16.7M -3.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 427M -2.2M -0.51% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 410M +135M +49.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 411M +170M +70.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 429M +192M +81% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 430M +193M +81.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 275M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 241M +9.29M +4.01% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 237M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 236M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q3 2019 232M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.